Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1 Study Evaluating PALI-2108 in Healthy Volunteers and Ulcerative Colitis Patients. [Phase 1]
A Phase 1 trial evaluating PALI-2108 in healthy volunteers and ulcerative colitis patients has completed, with focus on safety and tolerabil…
-
CLINICAL_TRIALS trial_result · 2025-07-28Clinical Trial Update: Fecal Transplant for Ulcerative Colitis [Phase 1]
Phase 1 trial evaluating fecal microbiota transplantation for Ulcerative Colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 3]
Phase 3 clinical trial of ustekinumab in pediatric participants with moderately to severely active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis [NA]
A completed clinical trial evaluating TRIple Rectal Ultrasound Imaging Technology in patients with Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis [Phase 2]
Pfizer-sponsored Phase 2 trial comparing etrasimod to placebo in moderately active ulcerative colitis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Vitamin D and Disease Activity in Ulcerative Colitis
This update notes the University of Chicago’s completed clinical trial assessing the relationship between vitamin D and disease activity in …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcerative Colitis
This ClinicalTrials.gov update indicates that the study evaluating ozanimod for ulcerative colitis has been terminated, reporting on utiliza…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis [Phase 2]
AbbVie’s Phase 2 trial evaluating oral NX-13 for moderate to severe ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 safety study of Lactobacillus reuteri BGP-014 in patients with Ulcerative C…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Evaluation of SPH3127 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating SPH3127 in mild-to-moderate ulcerative colitis was terminated, with results posted on ClinicalTrials.gov on 2025-06…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis [Phase 4]
A Phase 4 trial (EFFICACI) comparing intravenous infliximab versus vedolizumab in ulcerative colitis patients after failure of subcutaneous …
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]
A Phase 2 study evaluating OSE-127 versus placebo in moderate to severe active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® [Phase 3]
Phase 3 trial evaluating the efficacy, safety, and immunogenicity of the proposed vedolizumab biosimilar PB016 compared with Entyvio. The st…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD) [EARLY_Phase 1]
The early-phase trial of Serum Bovine Immunoglobulin (SBI) in children and young adults with inflammatory bowel disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study
Results from a UK matched-cohort study examine the risk of venous thromboembolism among people with systemic inflammatory disorders. The tri…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis [NA]
This clinical trial update reports on a completed study evaluating the use of intestinal ultrasound to assess pouchitis and other outcomes a…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD). [Phase 4]
Phase 4 trial evaluating prevention of recurrent Clostridioides difficile infection in patients with inflammatory bowel disease. The study w…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed …
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? [NA]
A clinical trial assessing whether to continue anti-TNF therapy in patients with ulcerative colitis in clinical remission has completed. The…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Adjunctive Treatment With Vitamin D3 in Patients With Active IBD [NA]
A clinical trial evaluating adjunctive vitamin D3 in patients with active inflammatory bowel disease has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease [NA]
A clinical trial evaluating a probiotic mixture for gut microbiome changes and fatigue in patients with quiescent inflammatory bowel disease…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients
Completed clinical trial examining the relationship between genetic polymorphisms of plasminogen activator inhibitor-1 and ulcerative coliti…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis
This clinical trial update reports the completion of a study evaluating Janus kinase inhibitors for acute severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease [NA]
A completed clinical trial examining how common sleep disorders are in inflammatory bowel disease and identifying factors associated with th…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities
The clinical trial sponsored by iThera Medical GmbH evaluating ultrasound and photoacoustic imaging to recognize intestinal abnormalities in…